317 related articles for article (PubMed ID: 31481117)
1. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
[TBL] [Abstract][Full Text] [Related]
2. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
3. Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy.
Kortekaas KE; Santegoets SJ; Tas L; Ehsan I; Charoentong P; van Doorn HC; van Poelgeest MIE; Mustafa DAM; van der Burg SH
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34716208
[TBL] [Abstract][Full Text] [Related]
4. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Xing D; Fadare O
Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
[TBL] [Abstract][Full Text] [Related]
5. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
6. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy.
Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI
Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410
[TBL] [Abstract][Full Text] [Related]
7. Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma.
Sznurkowski JJ; Żawrocki A; Biernat W
Oncotarget; 2017 Jul; 8(28):46204-46210. PubMed ID: 28515351
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
[TBL] [Abstract][Full Text] [Related]
9. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
[No Abstract] [Full Text] [Related]
10. Abnormal expression or mutation of TP53 and HPV in vulvar cancer.
Ngan HY; Cheung AN; Liu SS; Yip PS; Tsao SW
Eur J Cancer; 1999 Mar; 35(3):481-4. PubMed ID: 10448303
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden.
Larsson GL; Helenius G; Andersson S; Elgh F; Sorbe B; Karlsson MG
Int J Gynecol Cancer; 2012 Oct; 22(8):1413-9. PubMed ID: 23013732
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.
Rosenthal AN; Hopster D; Ryan A; Jacobs IJ
Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
[TBL] [Abstract][Full Text] [Related]
15. p53 Immunohistochemical Patterns in HPV-Independent Squamous Cell Carcinomas of the Vulva and the Associated Skin Lesions: A Study of 779 Cases.
Rakislova N; Alemany L; Clavero O; Saco A; Torné A; Del Pino M; Munmany M; Rodrigo-Calvo MT; Guerrero J; Marimon L; Vega N; Quirós B; Lloveras B; Ribera-Cortada I; Alejo M; Pawlita M; Quint W; de Sanjose S; Ordi J; Vvap Study Group
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138328
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
[TBL] [Abstract][Full Text] [Related]
17. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.
Del Pino M; Rodriguez-Carunchio L; Ordi J
Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170
[TBL] [Abstract][Full Text] [Related]
18. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
Tessier-Cloutier B; Kortekaas KE; Thompson E; Pors J; Chen J; Ho J; Prentice LM; McConechy MK; Chow C; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Bosse T; Hoang LN
Mod Pathol; 2020 Aug; 33(8):1595-1605. PubMed ID: 32203095
[TBL] [Abstract][Full Text] [Related]
19. Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.
van Esch EM; van Poelgeest MI; Kouwenberg S; Osse EM; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH
Int J Cancer; 2015 Feb; 136(4):E95-106. PubMed ID: 25220367
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.
Pinto AP; Lin MC; Mutter GL; Sun D; Villa LL; Crum CP
Am J Pathol; 1999 Apr; 154(4):1009-15. PubMed ID: 10233839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
